AI Article Synopsis

  • Quetiapine fumarate is a short-acting antipsychotic that typically requires multiple daily doses; this study aims to create a copolymer for controlled delivery of the drug.
  • Hydroxypropyl methylcellulose K15M (HPMC K15M) is added to the formulation to enhance patient compliance and reduce side effects, with varying concentrations tested between 10-30%.
  • The study utilized several analytical methods to examine the hydrogels' properties and found that increasing HPMC K15M concentration improved the drug's release profile, demonstrating a non-Fickian diffusion mechanism for drug release.

Article Abstract

Quetiapine fumarateis a typical antipsychotic with a short half-life of 6 h and is administered multiple times daily. In this study, a copolymer for controlled delivery of quetiapine fumarate will be developed. In order to prevent side effects and improve patient compliance, hydroxypropyl methylcellulose K15M (HPMC K15M) was included in the formulation of the quetiapine fumarate oral sustained-release tablets at a concentration of 10-30%. A series of analytical methods were used to determine the characteristics of the prepared hydrogels, including Fourier transform-infrared spectroscopy, Differential scanning calorimetry, X-ray diffraction, and Scanning electron microscope. At two different pH values (1.2 and 6.8), swelling and release studies were conducted. A variety of release kinetic models was used to study drug release mechanisms. A non-Fickian diffusion mechanism released hydrogels prepared from quetiapine fumarate. It was found that swelling was increased by increasing the amount of HPMC K15M. Compared to the other batches (10-20%), the produced tablets with 30% HPMC K15M content had a better release profile after 20 h of dissolution. Because of the effective matrix complex's limited solubility in water, the drug diffuses through the gel layer at a steady rate rather than dissolving quickly.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11545565PMC
http://dx.doi.org/10.1186/s13065-024-01311-2DOI Listing

Publication Analysis

Top Keywords

quetiapine fumarate
16
hpmc k15m
12
hydroxypropyl methylcellulose
8
release
6
quetiapine
5
influence physico-chemical
4
physico-chemical properties
4
properties hydroxypropyl
4
methylcellulose quetiapine
4
fumarate
4

Similar Publications

Objective: To study the features of the clinical picture and diagnosis of Parkinson's disease (PD) in patients with schizophrenia spectrum disorders (SSD).

Material And Methods: The analysis of databases of four psychoneurological dispensaries in Moscow with the allocation of groups of patients with diagnoses of SSD (F20-F25 according to ICD-10) was carried out. Among these groups, a targeted search for patients with an established diagnosis of PD (G20) was conducted.

View Article and Find Full Text PDF

The 5-hydroxytryptamine type (5-HT) receptor, a ligand-gated ion channel, plays a critical role in synaptic transmission. It has been implicated in various neuropsychiatric disorders. This study aimed to elucidate the mechanism by which quetiapine, an atypical antipsychotic, could inhibit 5-HT receptor-mediated currents in NCB20 neuroblastoma cells.

View Article and Find Full Text PDF

Although quetiapine metabolism occurs extensively in the liver and careful dosing is recommended in patients with liver disease, there has been a paucity of pharmacometric studies to adjust the clinical dose of quetiapine according to liver-disease severity. This study aimed to establish a whole-body, physiologically-based pharmacokinetic (WB-PBPK) model to explain interindividual variability in quetiapine PK and quantitatively predict PK in patients with liver disease. The developed WB-PBPK model well described the PK characteristics of different quetiapine regimens in healthy populations.

View Article and Find Full Text PDF

Background: Response to pharmacotherapy varies considerably among youths with bipolar disorder (BD) and is poorly predicted by clinical or demographic features. It can take several weeks to determine whether medication for BD is clinically effective. Although neuroimaging biomarkers are promising predictors, few studies examined the predictive value of the brain connectomic topology.

View Article and Find Full Text PDF
Article Synopsis
  • * This clinical trial aims to compare quetiapine monotherapy against treatment as usual (TAU) to see if it offers better recovery from postconcussive syndrome and PTSD symptoms in veterans undergoing rehabilitation for mTBI.
  • * The study will enroll 146 veterans over 12 weeks, focusing on outcomes like symptom reduction, functional disability, and quality of life, with the goal of determining if quetiapine can enhance recovery and improve overall well-being.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!